Publication | Closed Access

Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Concurrent ChemoradiotherapyHealth SciencesRadiation TherapyMedicineMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer ResearchPhase 3RadiologyN2–3 Nasopharyngeal Carcinoma